Malta Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

Dublin, Oct. 10, 2019 (GLOBE NEWSWIRE) -- The "Malta Nucleic Acid Testing (NAT) Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.

This new report from the author is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights

• Five-year test volume and sales forecasts
• Feature comparison of major analyzers
• Profiles of market players and start-up firms developing innovative technologies and products
• Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis

• Five-year test volume and sales forecasts for major applications.
• Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review

• Comparison of leading molecular diagnostic analyzers.
• Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
• Companies, universities and research centers developing new molecular-diagnostic technologies and products.

Competitive Assessments

• Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Opportunities and Strategic Recommendations

• New product development opportunities with potentially significant market appeal during the next five years.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Companies Mentioned

• Abbott
• Affymetrix
• Agilent Technologies
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Biokit
• bioMerieux
• Bio-Rad
• Biotest
• Cepheid
• Decode Genetics
• Diadexus
• Eiken Chemical
• Elitech Group
• Enzo Biochem
• Exact Sciences
• Fujirebio
• Grifols
• Hologic
• Illumina
• LabCorp
• Leica Biosystems
• Li-Cor Biosciences
• Myriad Genetics
• Ortho-Clinical Diagnostics
• PerkinElmer
• Proteome Sciences
• Qiagen
• Roche
• Scienion
• Sequenom
• Shimadzu
• Siemens Healthineers
• Sierra Molecular
• Takara Bio
• Tecan Group
• Thermo Fisher

For more information about this report visit https://www.researchandmarkets.com/r/a2xdvx

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900